Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer. - Burcher KM; Bloomer CH; Gavrila E; Kalada JM; Chang MJ; Gebeyehu RR; Song AH; Khoury LM; Lycan TW; Kinney R; D'Agostino R Jr; Bunch PM; et al. (Therapeutic advances in medical oncology, 2024)